Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 6 51-6, 2005, Pages

  Sundaram, Shikha S ^a   Whitington, Peter F ^a   Green, Richard M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cytokines; Nonalcoholic steatohepatitis; Oxidative stress

Indexed keywords

AMINOTRANSFERASE; CHOLINE; CYTOCHROME P450 2E1; FATTY ACID SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; METHIONINE; PREALBUMIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TUMOR NECROSIS FACTOR ALPHA;

ABCB11 GENE; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLINE DEFICIENCY; CYTOCHROME P-450 CYP2E1; DIET; FATTY LIVER; MALE; METHIONINE; MICE; MICE, TRANSGENIC; PREALBUMIN;

EID: 19644375041     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00455.2004     Document Type: Article

References (50)

1. Agellon LB, Walkey CJ, Vance DE, Kuipers F, and Verkade HJ. The unique acyl chain specificity of biliary phosphatidylcholines in mice is independent of their biosynthetic origin in the liver. Hepatology 30: 725-729, 1999.
2. T method for relative quantification. In: Sequence Detection Systems Chemistry Guide. Foster City, CA: Applied Biosystems, sect. 3.2, p. 3-35 and 33-39.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
4. Bobard A, Hainault I, Ferre P, Foufelle F, and Bossard P. Differential regulation of sterol regulatory element-binding protein le transcriptional activity by insulin and liver X receptor during liver development. J Bio-chem 280: 199-206, 2005.
5. Carey MC. The Liver: Biology and Pathobiology. New York: Raven, 1994.
6. Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, and McClain CJ. S-adenosylmethionine deficiency and TNF-α in lipopolysaccharide-induced hepatic injury. Am J Physiol Gastrointest Liver Physiol 275: G125-G129, 1998.
7. Chitturi S and Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21: 27-41, 2001.
8. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, and Pons-Romero F. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34: 1158-1163, 2001.
9. Eastin CE, McClain CJ, Lee EY, Bagby GJ, and Chawla RK. Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury. Alcohol Clin Exp Res 21: 1037-1041, 1997.
10. Edwards PA, Tabor D, Kast HR, and Venkateswaran A. Regulation of gene expression by SREBP and SCAP. Biochim Biophys Acta 1529: 103-113, 2000.
11. Ekstrom G and Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38: 1313-1319, 1989.
12. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A, Miranda M, Mari M, Ardite E, and Morales A. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol Gastrointest Liver Physiol 273: G7-G17, 1997.
13. Figge A, Lammert F, Paigen B, Henkel A, Matern S, Korstanje R, Shneider BL, Chen F, Stoltenberg E, Spatz K, Hoda F, Cohen DE, and Green RM. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J Biol Chem 279: 2790-2799, 2004.
14. Green RM. NASH-hepatic metabolism and not simply the metabolic syndrome. Hepatology 38: 14-17, 2003.
15. Hill MR and McCallum RE. Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice. Infect Immun 60: 4040-4050, 1992.
16. Horton JD, Goldstein JL, and Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131, 2002.
17. Horton JD and Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 10: 143-150, 1999.
18. Iimuro Y, Gallucci RM, Luster MI, Kono H, and Thurman RG. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26: 1530-1537, 1997.
19. Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, and Leclercq I. Central role of PPAR alpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38: 123-132, 2003.
20. Koppe SW, Sahai A, Malladi P, Whitington PF, and Green RM. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J Hepatol 41: 592-598, 2004.
21. Koteish A and Diehl AM. Animal models of steatosis. Semin Liver Dis 21: 89-104, 2001.
22. Kugelmas M, Hill DB, Vivian B, Marsano L, and McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 38: 413-419, 2003.
23. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, and Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105: 1067-1075, 2000.
24. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, and Diehl AM. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37: 343-350, 2003.
25. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, and Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37: 917-923, 2003.
26. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, and McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419, 1999.
27. McClain CJ, Hill DB, Song Z, Chawla R, Watson WH, Chen T, and Barve S. S-adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol 27: 185-192, 2002.
28. Meier PJ and Stieger B. Bile salt transporters. Annu Rev Physiol 64: 635-661, 2002.
29. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, Niwa M, Senoh H, and Fujiwara H. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179: 1529-1537, 1994.
30. Nanji AA, Zhao S, Sadrzadeh SM, Dannenberg AJ, Tahan SR, and Waxman DJ. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol Clin Exp Res 18: 1280-1285, 1994.
31. Rinella MGR. TTR-Abcb11 transgenic mice fed a high fat diet are obese, insulin resistant and develop hepatic steatosis (Abstract). Hepatology 38: 703, 2003.
32. Sahai A, Malladi P, Melin-Aldana H, Green RM, and Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287: G264-G273, 2004.
33. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, and Whitington PF. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287: G1035-G1043, 2004.
34. Sakakura Y, Shimano H, Sone H, Takahashi A, Inoue N, Toyoshima H, Suzuki S, Yamada N, and Inoue K. Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. Biochem Biophys Res Commun 286: 176-183, 2001.
35. Sekura R and Meister A. γ-Glutamylcysteine synthetase. Further purification, "half of the sites" reactivity, subunits, and specificity. J Biol Chem 252: 2599-2605, 1977.
36. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, and Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98: 1575-1584, 1996.
37. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, and Goldstein JL. Isoform le of sterol regulatory element binding protein is less active than isoform la in livers of transgenic mice and in cultured cells. J Clin Invest 99: 846-854, 1997.
38. Shimomura I, Bashmakov Y, and Horton JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274: 30028-30032, 1999.
39. Shimomura I, Shimano H, Korn BS, Bashmakov Y, and Horton JD. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 273: 35299-35306, 1998.
40. Taussky HH and Shorr E. A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202: 675-685, 1953.
41. Trauner M and Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83: 633-671, 2003.
42. Vance DE and Walkey CJ. Roles for the methylation of phosphatidylethanolamine. Curr Opin Lipidol 9: 125-130, 1998.
43. Walkey CJ, Yu L, Agellon LB, and Vance DE. Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem 273: 27043-27046, 1998.
44. Wang DQ, Lammert F, Paigen B, and Carey MC. Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology of biliary lipid secretion. J Lipid Res 40: 2066-2079, 1999.
45. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, and Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27: 128-133, 1998.
46. Weltman MD, Farrell GC, and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111: 1645-1653, 1996.
47. Wu G, Fang YZ, Yang S, Lupton JR, and Turner ND. Glutathione metabolism and its implications for health. J Nutr 134: 489-492, 2004.
48. Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Nagai R, Ishibashi S, and Yamada N. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 211: 19353-19357, 2002.
49. Yang SQ, Lin HZ, Lane MD, Clemens M, and Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94: 2557-2562, 1997.
50. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, and Thurman RG. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117: 942-952, 1999.